# Metaclipse Therapeutics Corp.

Canonical: https://abierto.us/vendors/metaclipse-therapeutics-corp-mu6jzbdzr8x1

- UEI: MU6JZBDZR8X1
- CAGE: 6BYQ1
- Location: Atlanta, GA
- Awards in window: 1 (2 transactions), $299,984 obligated, September 4, 2025 to August 11, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $299,984

## Industries

- 541713 Research and Development in Nanotechnology: $299,984

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91025C00038 (definitive contract): $299,984, NIH NCI. SBIR Concept Award for Development of Therapeutic or Preventative Technologies for Treatment or Prevention of Pediatric Cancers And/Or Rare Cancers. https://www.usaspending.gov/award/CONT_AWD_75N91025C00038_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/metaclipse-therapeutics-corp-mu6jzbdzr8x1.